Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Microcirculatory Mapping of the Aging Hand and Foot

This study has been completed.
Sponsor:
Information provided by:
Hannover Medical School
ClinicalTrials.gov Identifier:
NCT01235312
First received: November 4, 2010
Last updated: June 21, 2011
Last verified: June 2011
  Purpose

Currently, dorsal hand rejuvenation is an upcoming issue as patients seek plastic surgeons to address this highly visible area, although no specific statistics concerning the number of patients undergoing dorsal hand rejuvenation have been published yet. The solitary use of fillers, fat, sclerotherapy, skin excision, resurfacing and combinations of the above mentioned therapies have been reported in the literature, but still there is a lack of scientific literature about functional microcirculation of the dorsum of the hand.

Furthermore, there is a lack of scientific data about functional microcirculation of the plantar foot in healthy subjects compared to patients suffering from Diabetes mellitus or peripheral arterial occlusive disease. Consequently, the aim of this study is the evaluation of the functional microcirculation of hands and feet in healthy subjects as well as patients suffering from the above mentioned diseases.


Condition
Cutaneous Microcirculation in Vascular Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Hannover Medical School:

Primary Outcome Measures:
  • Correlation of microcirculation to age and incidence of vascular diseases [ Time Frame: 7 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: September 2010
Study Completion Date: May 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Healthy subjects
Patients suffering from Diabetes mellitus
Patients suffering from peripheral arterial occlusive disease

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Both healthy subjects and patients suffering from diabetes mellitus or manifested peripheral arterial occlusive disease

Criteria

Inclusion Criteria:

  • Both healthy subjects and patients suffering from diabetes mellitus or manifested peripheral arterial occlusive disease aged between 18 and 75 years

Exclusion Criteria:

  • soft tissue inflammation or osteomyelitis, liver disease, cardiac dysfunction, arterial hypotension
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01235312

Locations
Germany
Medical School Hannover
Hannover, Germany, 30625
Sponsors and Collaborators
Hannover Medical School
  More Information

No publications provided

Responsible Party: Hannover Medical School, Plastic, Hand and Reconstructive Surgery
ClinicalTrials.gov Identifier: NCT01235312     History of Changes
Other Study ID Numbers: Kraemer003
Study First Received: November 4, 2010
Last Updated: June 21, 2011
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 19, 2014